1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): A multicentre, single-arm clinical trial
    Journal Article

    Korenblik, R.; James, S.; Smits, J.; Díaz-Nieto, R.; Davis, R.; Chan, B. K. Y.; Erdmann, J. I.; Zijlstra, I. A. J.; Arntz, P. J. W.; Kollmar, O.; more...
    The Lancet Regional Health - Europe (2025)

    Fulltext@MSK | Save
  • Adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
    Journal Article

    Metzger Filho, O.; Ballman, K.; Campbell, J.; Liu, M.; Ligibel, J.; Watson, M.; Chen, E.; Du, L.; Stover, D.; Carey, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Multi-center, international endometrial cancer consortium highlights
    Editorial

    De Vitis, L.; Giudici, A.; Tarantino, V.; Ostby, S.; Bruce, K.; Breitkopf, D.; Olawaiye, A.; Eskander, R. N.; Coleman, R. L.; Momeni-Boroujeni, A.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Falchi, L.; Hutchings, M.; Carlo-Stella, C.; Morschhauser, F.; Dickinson, M.; Cartron, G.; Khan, C.; Tani, M.; Martinez-Lopez, J.; Bartlett, N. L.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Nodal status in major salivary gland cancer: External validation of a novel N- classification
    Journal Article

    Lombardi, D.; Tomasoni, M.; Missale, F.; Smeele, L. E.; Van Lierde, C.; Van Eecke, M.; Pellini, R.; Mazzola, F.; Ravanelli, M.; Farina, D.; more...
    European Journal of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies
    Journal Article

    Lopez, J. S.; Milhem, M.; Butler, M. O.; Thistlethwaite, F.; Van Tine, B. A.; D'Angelo, S. P.; Johnson, M. L.; Sato, T.; Arkenau, H. T.; Edukulla, R.; more...
    Cell Reports Medicine (2025)

    Fulltext@MSK | Save
  • Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: A real world analysis from 15 U.S. academic centers
    Journal Article

    Voorhees, T. J.; McLaughlin, E. M.; Torka, P.; Florindez, J.; Kim, N. H.; Moyo, T. K.; Reves, H.; Sumransub, N.; Deshpande, S.; Rose, A.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): An International Myeloma Working Group Study
    Journal Article

    Tan, C. R.; Asoori, S.; Huang, C. Y.; Brunaldi, L.; Popat, R.; Kastritis, E.; Martinez-Lopez, J.; Bansal, R.; Silva Corraes, A. D. M.; Chhabra, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Double hit & double expressor lymphomas: A multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
    Journal Article

    Karmali, R.; Shouse, G.; Torka, P.; Moyo, T. K.; Romancik, J.; Barta, S. K.; Bhansali, R.; Cohen, J. B.; Shah, N. N.; Zurko, J.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies
    Journal Article

    Roeker, L. E.; Coombs, C. C.; Shah, N. N.; Jurczak, W.; Woyach, J. A.; Cheah, C. Y.; Patel, K.; Maddocks, K.; Wang, Y.; Zinzani, P. L.; more...
    Acta Haematologica (2025)

    Fulltext@MSK | Save